Microsoft’s $20bn Acquisition of Nuance

–By Chen Xiangyu (Owen), University College London  DEAL OVERVIEW Acquirer: Microsoft Target: Nuance Communications Total Transaction Size: $19.7B Expected Closed date: Q3 2021 Acquirer advisor: Goldman Sachs Target advisor: Evercore Nuance Communications, a speech recognition and artificial intelligence software company, agreed to be acquired by Microsoft for $56 per share in an all-cash purchase worth $19.7 billion, that including the company’s debt.Continue reading “Microsoft’s $20bn Acquisition of Nuance”

Liberty Global and Telefonica to merge their UK operations in a €35.2B merger

-By Chen Xiangyu (Owen), University College London DEAL OVERVIEW Acquirer: Liberty GlobalTarget: TelefonicaEstimated value: €35.2 BillionAnnouncement date: 7 May 2020Acquirer Advisor: JPMorgan ChaseTarget Advisor: Citigroup Liberty Global Plc and Telefonica S.A. will establish a 50:50 joint venture in which LibertyGlobal will provide its €21 billion UK-based subsidiaries Virgin Media and Telefonica willprovide its €14.2 billionContinue reading “Liberty Global and Telefonica to merge their UK operations in a €35.2B merger”

$30B Aercap acquisition of Gecas creates a giant in the aircraft leasing industry 

-By Josh Abraham, London School of Economics DEAL OVERVIEW Acquirer: AerCap  Target: General Electric Capital Aviation Services (Gecas)  Value: US$30 billion ($24 billion in cash, 46% ownership stake in combined company, $1 billion in AerCap notes and/or cash upon closing)  Announced date: March 10th, 2021  Closed date: Ongoing  Financial Advisors: Citi and Morgan Stanley for Aercap, PJT Partners LP, Goldman Sachs, and Evercore for Gecas  Legal Counsel: Cravath, SwaineContinue reading “$30B Aercap acquisition of Gecas creates a giant in the aircraft leasing industry “

Teladoc’s $18.5B merger with Livongo

–Authored by Xueyiting Wang, King’s College London Overview of the deal Acquirer: Teladoc Health Target: Livongo Estimated Value: $18.5B Announced Date: 8/5/2020 Closed Date: 10/30/2020 Transaction Advisor(s): Lazard served as exclusive financial advisor to Teladoc Health and Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal advisor. Morgan Stanley served as exclusive financial advisorContinue reading “Teladoc’s $18.5B merger with Livongo”

AstraZeneca closes the acquisition of Alexion Pharmaceuticals

-By Youssef El Madani, University College London DEAL OVERVIEW Acquirer: AstraZeneca Target: Alexion Pharmaceuticals Total Transaction Size: $39 billion Closed date: July 21th 2021 Financial advisor to AstraZeneca: BofA Securities Financial advisors to Alexion: Evercore Partners, Centerview Partners In the largest deal of its history and the third-largest of 2020, pharmaceutical giant AstraZeneca has acquiredContinue reading “AstraZeneca closes the acquisition of Alexion Pharmaceuticals”

After acquiring Varian for $16.5B, Siemens Healthineers has the most comprehensive portfolio in the medtech sector

-Youssef El Madani, Kings College London Deal Overview Acquirer: Siemens Healthineers Target: Varian Medical Systems Total Transaction Value: $16.5 billion Close Date: Q2 2021 Target Advisor: Goldman Sachs On April 15th 2021, Siemens Healthineers annouced the closing of Varian Medical Systems’ acquisition, putting the German-based healtchare giant in the lead in the global radiation therapyContinue reading “After acquiring Varian for $16.5B, Siemens Healthineers has the most comprehensive portfolio in the medtech sector”

Uber asserts its dominance on third-party delivery market after acquiring Postmates for $2.65B

-By Ghali Moutawakil, University College London DEAL OVERVIEW Acquirer: Uber Technologies Target: Postmates Total Transaction Value: $2.65 billion Close Date: December 1st, 2020 Target Advisor: JPMorgan Securities LLC Uber announced, on December 1st 2020, the closing of its acquisition of Postmates in a $2.65 billion all-stock deal. This deal, which brings together two of theContinue reading “Uber asserts its dominance on third-party delivery market after acquiring Postmates for $2.65B”

Huntington’s $22B Merger with TCF

–Authored by Xueyiting Wang, King’s College London Overview of the deal Acquirer: Huntington Bank Target: TCF Bank Estimated Value: $22 billion Announced Date: 13th December 2020 Closed Date: 9th June 2021 Transaction Advisor(s): Goldman Sachs & Co. LLC is serving as financial advisor to Huntington. Wachtell, Lipton, Rosen & Katz is serving as legal advisorContinue reading “Huntington’s $22B Merger with TCF”

Gilead Sciences acquires Immunomedics for $21B

-By Chen Xiangyu (Owen), University College London deal overview Acquirer: Gilead Sciences Inc. Target: Immunomedics Inc. Total Transaction Value: $21 Billion Close Date: Q4 2020 Acquirer Advisor: Lazard and Morgan Stanley & Co. LLC Target Advisor:. Centerview Partners LLC and Bank of America Securities Gilead Sciences, Inc. completed the purchase of Immunomedics for $21 billionContinue reading “Gilead Sciences acquires Immunomedics for $21B”

7-Eleven completes the Aquisition of Speedway

-By Josh Abraham, London School of Economics DEAL OVERVIEW Acquirer: Seven & i Holdings (holding company of 7-Eleven)  Target: Speedway (subsidiary of Marathon Petroleum)  Value: US$21 billion  Announced date: August 3rd, 2020  Closed date: May 14th , 2021  Financial Advisors: Nomura Securities International Inc. and Credit Suisse for 7-Eleven  Legal Counsel: Akin Gump Strauss Hauer & Feld LLP, and Nishimura & Asahi for 7-Eleven     Company details Acquiring company:Continue reading “7-Eleven completes the Aquisition of Speedway”